inno.N’s R&D
Through continuous innovation and aggressive R&D, inno.N re-writes the history of rising to the challenge. While upgrading its pipeline with competitive candidate drugs for the circulatory system, metabolic system, the gastrointestinal system as well as IV products, inno.N also invests heavily in the research and development of new drugs for gastrointestinal diseases, immune diseases, infections and vaccines.
Novel Drug Research Center
Based on its extensive experience in drug development, inno.N has successfully launched a new product called ‘K-CAB Tab.’, A treatment for gastroesophageal reflux disease in Korea. inno.N is gradually expanding its market by focusing on gastrointestinal, cancer and immunological drugs to meet the high demand of the open market. In parallel, inno.N is continuing to implement many projects “Research & amp; Innovation ”with leading R & amp; D companies in Korea, Japan, the US and Europe to accelerate the development of potential new drugs and expand the R & D network globally.
Key roles
- Research on novel synthetic drugs and processes for API
- Research on the format of pharmaceutical drugs
- Analysis and assessment
Key roles
- Research on novel synthetic drugs and processes for API
- Research on the format of pharmaceutical drugs
- Analysis and assessment
Biology Research Center
The R&D capabilities that made the commercialization of interferon alpha/beta, GCSF and EPO possible are now geared towards developing a variety of drugs based on biological mechanisms. Current R&D in the area include second generation protein drugs, differentiated products focusing on antibodies, vaccines, and cell and gene therapy.
Key roles
- Overall research on related technologies
- Research on cells and genes
- Research on vaccines
Key roles
- Overall research on related technologies
- Research on cells and genes
- Research on vaccines
Health and Beauty Research Center
Drawing on its experience of having conducted research and development on Condition and Oriental Raisin water, both of which are perennial steady-sellers, the Institute has been focusing on the development of materials and ingredients that can be individually recognized for their efficacy in treating chronic diseases and age-related medical conditions, in addition to branded blockbuster consumer goods offering new health benefits.
Key roles
- Research on anti-hangover beverages and other functional beverages
- Research on health supplements
- Discovery of and research on individually recognized ingredients
Key roles
- Research on anti-hangover beverages and other functional beverages
- Research on health supplements
- Discovery of and research on individually recognized ingredients
R&D strategies
Focus on Disease
Development of global novel drugs and buiopharmaceuticals
Open Innovation
Accelerated research and active C&D for value creation
Continued Expansion of Growth Engines
Export of global products and Development of high-profit, synergistic products
Maximized Future Value
Development of microbiones and cell & gene therapy, acquisition of platform technologies
R&D investment
